Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-015542
Filing Date
2025-05-08
Accepted
2025-05-08 16:52:58
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q siga20250331_10q.htm   iXBRL 10-Q 612085
2 EXHIBIT 10.1 ex_807285.htm EX-10.1 116805
3 EXHIBIT 10.2 ex_807286.htm EX-10.2 98653
4 EXHIBIT 31.1 ex_763791.htm EX-31.1 15580
5 EXHIBIT 31.2 ex_763792.htm EX-31.2 15706
6 EXHIBIT 32.1 ex_763793.htm EX-32.1 5896
7 EXHIBIT 32.2 ex_763794.htm EX-32.2 5906
  Complete submission text file 0001437749-25-015542.txt   4684133

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA siga-20250331.xsd EX-101.SCH 54300
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE siga-20250331_cal.xml EX-101.CAL 34923
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE siga-20250331_def.xml EX-101.DEF 303215
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20250331_lab.xml EX-101.LAB 271796
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20250331_pre.xml EX-101.PRE 332469
74 EXTRACTED XBRL INSTANCE DOCUMENT siga20250331_10q_htm.xml XML 582470
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38436 | Film No.: 25927107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)